Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0352
+0.0012 (3.53%)
At close: Oct 15, 2025
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $1.47 million as of October 16, 2025. Its market cap has decreased by -96.49% in one year.
Market Cap
1.47M
Enterprise Value
1.17M
Revenue
10.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 1.47M, a decrease of -99.00%. That is a compound annual growth rate of -82.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 1.42M | -91.87% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |